CARB-X
CARB-X is a public investment body based in the United States, investing in Healthcare & Life Sciences, Pharmaceutical Development and Biotech, 2 tracked investments.
About CARB-X
Operating out of the United States, CARB-X is a public investment body. Our dataset covers 2 investments involving CARB-X.
Recorded deals span Healthcare & Life Sciences, Pharmaceutical Development, Biotech and Drug Development. Coverage extends to 8 sectors in total. Participation spans Series A and Series B rounds.
CARB-X is a non-profit accelerating antibacterial products to address drug-resistant bacteria. They fund the development of antibiotics, preventatives, rapid diagnostics and other life-saving products, supporting projects through early phases of development.
Investment Focus
Explore CARB-X's full profile on Brouky
Portfolio companies, co-investors, AI match scores, and deal flow signals.
Other Investors in United States
Carbon Direct Capital Management
Consumer, Lifestyle & Services, Energy, Environment & Mobility, Circular Economy
Carbon Direct Capital
Industry & Hardware, GEOINT, geospatial-intelligence
Carbide Ventures
Software & Developer Tools, Cybersecurity, Developer Tools
Captivate Partners
Healthcare & Life Sciences, sustainability, beauty
Cardea Investment Holdings
Industry & Hardware, Advanced Manufacturing, Hardware
Cardinal Health
Healthcare & Life Sciences, Healthcare Tech, Investment Management
Cardinal Partners
Healthcare & Life Sciences, biotechnology, pharmaceuticals
Card Sound Partners
Software & Developer Tools, Industrial Tech, sustainability